Skip to main content

Sangamo Therapeutics, Inc

SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001001233

No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Sangamo Therapeutics, Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
130
−5 vs. Q3 2023
Shares held
87.0M
−15.2M (−14.9%) vs. Q3 2023
Total value
$47.2M
−$14.1M (−23.1%) vs. Q3 2023
New holders
19
42 more added
Sold out
24
43 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 130 institutions
Q1 2021: 203 institutionsQ2 2021: 197 institutionsQ3 2021: 193 institutionsQ4 2021: 193 institutionsQ1 2022: 195 institutionsQ2 2022: 188 institutionsQ3 2022: 197 institutionsQ4 2022: 182 institutionsQ1 2023: 180 institutionsQ2 2023: 152 institutionsQ3 2023: 135 institutionsQ4 2023: 130 institutionsQ1 2024: 131 institutionsQ2 2024: 129 institutionsQ3 2024: 103 institutionsQ4 2024: 128 institutionsQ1 2025: 122 institutionsQ2 2025: 114 institutionsQ3 2025: 112 institutionsQ4 2025: 105 institutionsQ1 2026: 112 institutionsQ2 2026: 6 institutions
Value heldQ4 2023: $47.2M
Q1 2021: $994.7MQ2 2021: $912.0MQ3 2021: $679.3MQ4 2021: $577.0MQ1 2022: $459.6MQ2 2022: $371.1MQ3 2022: $477.2MQ4 2022: $326.0MQ1 2023: $197.6MQ2 2023: $137.4MQ3 2023: $61.3MQ4 2023: $47.2MQ1 2024: $68.2MQ2 2024: $31.1MQ3 2024: $48.6MQ4 2024: $62.9MQ1 2025: $34.5MQ2 2025: $39.6MQ3 2025: $42.1MQ4 2025: $26.2MQ1 2026: $26.0MQ2 2026: $29.0K
Institutions holding SGMOQ and their total value by quarter
QuarterHoldersValue
Q2 20266$29.0K
Q1 2026112$26.0M
Q4 2025105$26.2M
Q3 2025112$42.1M
Q2 2025114$39.6M
Q1 2025122$34.5M
Q4 2024128$62.9M
Q3 2024103$48.6M
Q2 2024129$31.1M
Q1 2024131$68.2M
Q4 2023130$47.2M
Q3 2023135$61.3M
Q2 2023152$137.4M
Q1 2023180$197.6M
Q4 2022182$326.0M
Q3 2022197$477.2M
Q2 2022188$371.1M
Q1 2022195$459.6M
Q4 2021193$577.0M
Q3 2021193$679.3M
Q2 2021197$912.0M
Q1 2021203$994.7M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q3 2023.

Institutions holding SGMOQ in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.340,693$185.0K0.00%−103,255−23.3%Reduced
Tudor Investment Corp Et Al363,490$197.5K0.00%00.0%Unchanged
Macquarie Group Ltd400,000$217.0K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA422,757$229.7K0.00%+249,617+144.2%Added
Bank of New York Mellon Corp496,388$269.7K0.00%−4,953−1.0%Reduced
Zacks Investment Management550,604$298.9K0.00%+550,604New
Dimensional Fund Advisors LP575,065$312.8K0.00%−228,826−28.5%Reduced
HighTower Advisors, LLC791,210$382.0K0.00%−351,930−30.8%Reduced
Nuveen Asset Management, LLC737,464$400.7K0.00%+20,936+2.9%Added
Morgan Stanley909,006$493.9K0.00%+145,786+19.1%Added
Jacobs Levy Equity Management, Inc1,008,062$547.7K0.00%+604,280+149.7%Added
Assenagon Asset Management S.A.1,033,322$561.4K0.00%+129,811+14.4%Added
Gsa Capital Partners LLP1,075,690$584.0K0.05%+515,959+92.2%Added
Millennium Management LLC1,122,599$609.9K0.00%+746,166+198.2%Added
Charles Schwab Investment Management Inc1,206,879$655.7K0.00%+15,677+1.3%Added
Citadel Advisors LLC1,231,296$669.0K0.00%−3,301,619−72.8%Reduced
Northern Trust Corp1,266,816$688.3K0.00%+76,869+6.5%Added
Long Focus Capital Management, LLC1,372,000$745.4K0.10%00.0%Unchanged
JPMorgan Chase & Co1,373,275$746.1K0.00%−32,871−2.3%Reduced
Two Sigma Advisers, LP2,085,255$1.13M0.00%+1,242,300+147.4%Added
Two Sigma Investments, LP2,174,133$1.18M0.00%+1,277,706+142.5%Added
Hudson Bay Capital Management LP2,500,000$1.36M0.01%+1,201,500+92.5%Added
State Street Corp2,708,368$1.47M0.00%+22,283+0.8%Added
Renaissance Technologies LLC3,145,878$1.71M0.00%+780,124+33.0%Added
Geode Capital Management, LLC3,206,310$1.74M0.00%+208,384+7.0%Added
D. E. Shaw & Co., Inc.4,683,973$2.54M0.00%+2,175,388+86.7%Added
Acadian Asset Management LLC4,750,875$2.58M0.01%+1,823,106+62.3%Added
Wasatch Advisors Inc12,397,924$6.74M0.04%−5,588,857−31.1%Reduced
Vanguard Group Inc12,599,129$6.85M0.00%+68,884+0.5%Added
BlackRock Inc.14,095,865$7.66M0.00%−1,701,091−10.8%Reduced
Rokos Capital Management LLP0$00.00%−6,474,348−100.0%Sold out
Credit Suisse AG0$00.00%−3,700,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−1,890,425−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−676,189−100.0%Sold out
Man Group plc0$00.00%–Sold out
Graham Capital Management, L.P.0$00.00%−96,102−100.0%Sold out
Penserra Capital Management LLC0$00.00%−87,000−100.0%Sold out
MetLife Investment Management0$00.00%−67,978−100.0%Sold out
XTX Topco Ltd0$00.00%−46,486−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−24,405−100.0%Sold out
Public Employees Retirement Association of Colorado0$00.00%−21,524−100.0%Sold out
Victory Capital Management Inc0$00.00%−16,738−100.0%Sold out
Mariner, LLC0$00.00%−16,437−100.0%Sold out
Point72 Middle East FZE0$00.00%−15,709−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−14,281−100.0%Sold out
Main Street Research LLC0$00.00%−10,000−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−7,330−100.0%Sold out
US Bancorp0$00.00%−5,000−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−4,546−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−2,173−100.0%Sold out
HighMark Wealth Management LLC0$00.00%−1,000−100.0%Sold out
Whittier Trust Co0$00.00%−381−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−498−100.0%Sold out
CWM, LLC0$00.00%−84−100.0%Sold out